fluoxetine has been researched along with Blood Pressure, High in 23 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our study aimed to evaluate the effect of fluoxetine on morning blood pressure surge (MBPS) in patients with ischemic stroke." | 8.02 | The effect of fluoxetine on morning blood pressure surge in patients with ischemic stroke: a prospective preliminary clinical study. ( Cai, Z; Deng, J; Guo, Y; He, Y; Zhang, H; Zhang, Y, 2021) |
| "A case of branch retinal vein occlusion associated with fluoxetine-induced secondary hypertension is described." | 7.74 | Branch retinal vein occlusion and fluoxetine. ( Knox Cartwright, NE; Smith, P; Tole, DM, 2007) |
| "In keeping with the anxiolytic property of selective serotonin reuptake inhibitors (SSRIs) in humans, we have examined in the spontaneously hypertensive rat (SHR) and the Wistar-Kyoto (WKY) rat, which display low and high anxiety, respectively, some psychoneuroendocrine effects of a repeated treatment with the SSRI fluoxetine (5 or 10 mg/kg daily, for 3 weeks)." | 7.70 | Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats. ( Aguerre, S; Berton, O; Chaouloff, F; Combourieu, I; Durand, M; Edno, L; Mormède, P, 1999) |
| "Our study aimed to evaluate the effect of fluoxetine on morning blood pressure surge (MBPS) in patients with ischemic stroke." | 4.02 | The effect of fluoxetine on morning blood pressure surge in patients with ischemic stroke: a prospective preliminary clinical study. ( Cai, Z; Deng, J; Guo, Y; He, Y; Zhang, H; Zhang, Y, 2021) |
| "A case of branch retinal vein occlusion associated with fluoxetine-induced secondary hypertension is described." | 3.74 | Branch retinal vein occlusion and fluoxetine. ( Knox Cartwright, NE; Smith, P; Tole, DM, 2007) |
| "In keeping with the anxiolytic property of selective serotonin reuptake inhibitors (SSRIs) in humans, we have examined in the spontaneously hypertensive rat (SHR) and the Wistar-Kyoto (WKY) rat, which display low and high anxiety, respectively, some psychoneuroendocrine effects of a repeated treatment with the SSRI fluoxetine (5 or 10 mg/kg daily, for 3 weeks)." | 3.70 | Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats. ( Aguerre, S; Berton, O; Chaouloff, F; Combourieu, I; Durand, M; Edno, L; Mormède, P, 1999) |
| "Outpatients with recurrent unipolar depression (DSM-IV criteria; N = 1096) were randomly assigned in a 3:1 ratio to 10 weeks of treatment with venlafaxine ER or fluoxetine." | 2.73 | The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. ( Ahmed, S; Dunner, DL; Ferguson, JM; Friedman, ES; Gelenberg, AJ; Hirschfeld, RM; Keller, MB; Kocsis, JH; Kornstein, SG; Musgnung, J; Nemeroff, CB; Ninan, PT; Pedersen, RD; Rothschild, AJ; Schatzberg, AF; Shelton, RC; Thase, ME; Trivedi, MH; Yan, B; Zajecka, JM, 2007) |
| "nortriptyline) was done." | 2.70 | Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline. ( Clary, CM; Doraiswamy, PM; Krishnan, KR, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 9 (39.13) | 18.2507 |
| 2000's | 9 (39.13) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y | 1 |
| Deng, J | 1 |
| Zhang, Y | 1 |
| Cai, Z | 1 |
| Zhang, H | 1 |
| Guo, Y | 1 |
| de Vries-Bouwstra, JK | 1 |
| Allanore, Y | 1 |
| Matucci-Cerinic, M | 1 |
| Balbir-Gurman, A | 1 |
| Kosiorek-Witek, A | 1 |
| Makulska-Nowak, HE | 1 |
| Applebee, GA | 1 |
| Attarian, HP | 1 |
| Schenck, CH | 1 |
| Akarachkova, ES | 1 |
| Tabeeva, GR | 1 |
| Volkova, ZI | 1 |
| Dlusskaia, IG | 1 |
| Striuk, RI | 1 |
| Veĭn, AM | 1 |
| Gillman, PK | 1 |
| Cai, XJ | 1 |
| Bi, XP | 1 |
| Zhao, Z | 1 |
| Wang, L | 1 |
| Keller, MB | 1 |
| Trivedi, MH | 1 |
| Thase, ME | 1 |
| Shelton, RC | 1 |
| Kornstein, SG | 2 |
| Nemeroff, CB | 1 |
| Friedman, ES | 1 |
| Gelenberg, AJ | 1 |
| Kocsis, JH | 1 |
| Dunner, DL | 1 |
| Hirschfeld, RM | 1 |
| Rothschild, AJ | 1 |
| Ferguson, JM | 1 |
| Schatzberg, AF | 1 |
| Zajecka, JM | 1 |
| Pedersen, RD | 1 |
| Yan, B | 1 |
| Ahmed, S | 1 |
| Musgnung, J | 1 |
| Ninan, PT | 1 |
| Knox Cartwright, NE | 1 |
| Smith, P | 1 |
| Tole, DM | 1 |
| Carlson, JA | 1 |
| Mazza, J | 1 |
| Kircher, K | 1 |
| Tran, TA | 1 |
| Sved, AF | 1 |
| Van Itallie, CM | 1 |
| Fernstrom, JD | 1 |
| Coulter, DM | 1 |
| Pillans, PI | 1 |
| Montastruc, JL | 1 |
| Chamontin, B | 1 |
| Senard, JM | 1 |
| Tran, MA | 1 |
| Rascol, O | 1 |
| Llau, ME | 1 |
| Rascol, A | 1 |
| Nyquist-Battie, C | 1 |
| Cochran, PK | 1 |
| Evans, VR | 1 |
| Hitchcock, JM | 1 |
| Unal, C | 1 |
| Azaz-Livshits, TL | 1 |
| Danenberg, HD | 1 |
| Amsterdam, JD | 1 |
| Garcia-Espana, F | 1 |
| Fawcett, J | 1 |
| Quitkin, FM | 1 |
| Reimherr, FW | 1 |
| Rosenbaum, JF | 1 |
| Beasley, C | 1 |
| Durand, M | 1 |
| Berton, O | 1 |
| Aguerre, S | 1 |
| Edno, L | 1 |
| Combourieu, I | 1 |
| Mormède, P | 1 |
| Chaouloff, F | 1 |
| Boylan, LS | 1 |
| Krishnan, KR | 1 |
| Doraiswamy, PM | 1 |
| Clary, CM | 1 |
| Fuller, RW | 1 |
| Holland, DR | 1 |
| Yen, TT | 1 |
| Bemis, KG | 1 |
| Stamm, NB | 1 |
| Suchowersky, O | 1 |
| deVries, JD | 1 |
| Hansen, TE | 1 |
| Dieter, K | 1 |
| Keepers, GA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Acute and Continuation Phase Study of the Comparative Efficacy Study of Venlafaxine ER (Effexor® XR) and Fluoxetine (Prozac®) in Achieving and Sustaining Remission (Wellness) in Patients With Recurrent Unipolar Major Depression; Followed by a Long Term[NCT00046020] | Phase 4 | 1,096 participants (Actual) | Interventional | 2000-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for fluoxetine and Blood Pressure, High
| Article | Year |
|---|---|
Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study.
Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Delayed-Ac | 2008 |
4 trials available for fluoxetine and Blood Pressure, High
| Article | Year |
|---|---|
[The effects of antidepressant treatment on efficacy of antihypertensive therapy in elderly hypertension].
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Bloo | 2006 |
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depress | 2007 |
Blood pressure changes during short-term fluoxetine treatment.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Depression; Doubl | 1999 |
Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline.
Topics: Age of Onset; Aged; Antidepressive Agents; Anxiety; Cardiovascular Diseases; Comorbidity; Depressive | 2001 |
18 other studies available for fluoxetine and Blood Pressure, High
| Article | Year |
|---|---|
The effect of fluoxetine on morning blood pressure surge in patients with ischemic stroke: a prospective preliminary clinical study.
Topics: Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brain Ischemia; Circadian Rhythm; Fluoxetine; | 2021 |
Worldwide Expert Agreement on Updated Recommendations for the Treatment of Systemic Sclerosis.
Topics: Adrenal Cortex Hormones; Angiotensin-Converting Enzyme Inhibitors; Europe; Fluoxetine; Gastroesophag | 2020 |
Morphine Analgesia Modification in Normotensive and Hypertensive Female Rats after Repeated Fluoxetine Administration.
Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Estrous Cycle; Female; Fluoxetine; Hyp | 2016 |
An angry bed partner.
Topics: Anger; Antidepressive Agents, Second-Generation; Bupropion; Coronary Artery Disease; Depressive Diso | 2009 |
[Clinical significance of adrenoreactivity in patients with some paroxysmal disorders (panic attacks and migraine)].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Citalopram; Diagnostic and Statistical Manual of Men | 2003 |
Re: no evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline.
Topics: Antidepressive Agents; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; Fluoxetine; Humans | 2005 |
Branch retinal vein occlusion and fluoxetine.
Topics: Adult; Female; Fluoxetine; Fundus Oculi; Humans; Hypertension; Retinal Vein Occlusion; Selective Ser | 2007 |
Otophyma: a case report and review of the literature of lymphedema (elephantiasis) of the ear.
Topics: Adrenal Cortex Hormones; Alcoholism; Anti-Infective Agents; Anti-Inflammatory Agents; Antidepressive | 2008 |
Studies on the antihypertensive action of L-tryptophan.
Topics: Amino Acids; Animals; Antihypertensive Agents; Blood Pressure; Drug Interactions; Fenclonine; Fluoxe | 1982 |
Hypertension with moclobemide.
Topics: Adult; Aged; Antidepressive Agents; Benzamides; Cohort Studies; Drug Interactions; Female; Fluoxetin | 1995 |
Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegiline.
Topics: Adrenal Gland Neoplasms; Adult; Catecholamines; Diagnosis, Differential; Drug Interactions; Female; | 1993 |
Regulation of sympathetic presynaptic components in rat left ventricle during ligation of abdominal aorta.
Topics: Animals; Aorta, Abdominal; Binding Sites; Carrier Proteins; Fluoxetine; Hypertension; Ligation; Male | 1996 |
Tachycardia, orthostatic hypotension and profound weakness due to concomitant use of fluoxetine and nifedipine.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Calcium Channel Blockers; Drug Interactions; Drug | 1997 |
Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats.
Topics: Animals; Anxiety; Basal Metabolism; Behavior, Animal; Drug Administration Schedule; Fluoxetine; Hipp | 1999 |
Mutual influences between paroxysmal hypertension and psychiatric disturbance.
Topics: Aged; Antidepressive Agents, Second-Generation; Autonomic Nervous System Diseases; Blood Pressure; D | 1999 |
Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats.
Topics: 5-Hydroxytryptophan; Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Drug In | 1979 |
Interaction of fluoxetine and selegiline.
Topics: Bipolar Disorder; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine | 1990 |
Interaction of fluoxetine and pentazocine.
Topics: Adult; Anxiety; Ataxia; Drug Interactions; Fluoxetine; Humans; Hypertension; Male; Nausea; Paresthes | 1990 |